Key Record Dates
ClinicalTrials.gov Identifier: | NCT05908734 |
---|---|
Brief Title: | A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer (PolyDamas) |
First Submitted : | June 6, 2023 |
First Submitted that Met QC Criteria : | June 16, 2023 |
First Posted : | June 18, 2023 |
Last Update Submitted that Met QC Criteria : | April 23, 2024 |
Last Update Posted : | April 24, 2024 |